SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-017696
Filing Date
2020-04-21
Accepted
2020-04-21 16:18:10
Documents
5
Effectiveness Date
2020-04-21

Document Format Files

Seq Description Document Type Size
1 DEFA14A rcus-defa14a_20191231.htm DEFA14A 18848
2 GRAPHIC g5aomctbumt2000003.jpg GRAPHIC 12167
3 GRAPHIC g5aomctbumt2000004.jpg GRAPHIC 6037
4 GRAPHIC g5aomctbumt2000002.jpg GRAPHIC 56695
5 GRAPHIC g5aomctbumt2000001.jpg GRAPHIC 35321
  Complete submission text file 0001564590-20-017696.txt   172205
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38419 | Film No.: 20805356
SIC: 2834 Pharmaceutical Preparations